|Bid||146.14 x 800|
|Ask||146.27 x 2200|
|Day's Range||144.84 - 146.98|
|52 Week Range||91.75 - 152.10|
|Beta (5Y Monthly)||1.24|
|PE Ratio (TTM)||47.99|
|Earnings Date||Feb 12, 2020 - Feb 17, 2020|
|Forward Dividend & Yield||0.64 (0.44%)|
|1y Target Est||150.00|
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2020 dividend of $0.16 per share. The dividend will be paid on February 5, 2020, to shareholders of record as of January 22, 2020.
NextGen Healthcare (NXGN) is likely to boost presence in health management with CHC Strategies delivering quality medical care through the company's Population Health platform.
NextGen Healthcare (NXGN) is gaining traction from the U.S. RCM market and the growing EHR market. However, margin pressure remains a concern.
Nevro (NVRO) is gaining traction from strengthening international footprint and solid prospects in the SCS market. However, stiff competition remains a woe.
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. Since stock returns aren't usually symmetrically distributed and index […]
Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. To keep it practical...
EXTON, Pa., Nov. 19, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at the Jefferies 2019 London Healthcare Conference in London, United Kingdom on Wednesday, November 20, 2019. West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Trademarks and registered trademarks are the property of West Pharmaceutical Services, Inc. in the United States and other jurisdictions, unless noted otherwise.
FRANKFURT, Germany, Nov. 6, 2019 /PRNewswire/ -- (Booths #F62 & #F10 -Hall 11.1) West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, and the international technology group SCHOTT, a leading primary packaging solutions provider, today announced a partnership to combine the SCHOTT iQ® platform with West's Ready Pack™ system. The collaboration will initially launch by combining West components and SCHOTT's adaptiQ® high-quality RTU glass vials and will expand to include other convenient, ready-to-use combinations of West and SCHOTT products, to be available on a small-quantity basis.
EXTON, Pa., Nov. 5, 2019 /PRNewswire/ -- (Booth #111F62)—West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced two innovative product offerings in the elastomer space at the 2019 CPhI Worldwide conference in Frankfurt, Germany. West introduced its advanced elastomer, the new 4040/40 formulation, created with customer insight to deliver enhanced performance and reliability, while helping to mitigate risk for customers.
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side...
West Pharmaceutical (WST) delivered earnings and revenue surprises of 11.27% and 0.81%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 24, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter ...
Scientific Presentations & Trainings Highlight Scientific Leadership in Drug Containment & Delivery EXTON, Pa. , Oct. 22, 2019 /PRNewswire/ -- (Booths #F44 & #F51)— West Pharmaceutical Services, Inc. ...
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]
West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EXTON, Pa., Oct. 16, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced that it has increased its minority equity stake to 49 percent in Daikyo Seiko, Ltd., a company that West has partnered with for more than 40 years to develop and manufacture high-quality components and solutions for the primary containment and delivery of injectable medicines. West and Daikyo have long-standing agreements which include a distribution agreement, by which West distributes and markets Daikyo products throughout the world, on an exclusive basis, as well as a technology exchange and cross license agreement, which grants each party certain exclusive intellectual property rights for the manufacture of products covered by the relationship.
EXTON, Pa., Oct. 10, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2019 financial results before the market opens on Thursday, October 24, 2019, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 9278868. An online archive of the broadcast will be available at the West website three hours after the live call and will be available through Thursday, October 31, 2019, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International).
Today we'll evaluate West Pharmaceutical Services, Inc. (NYSE:WST) to determine whether it could have potential as an...